Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 88

    Merck Ebola Vaccine V920 up for USFDA review

    Merck Ebola Vaccine V920 up for USFDA review

    Medical Dialogues Bureau20 Sept 2019 9:30 AM IST
    New Delhi: Merck, known as MSD outside the United States and Canada, recently announced that the U.S. Food and Drug Administration (FDA) has accepted...
    GSK fights bid to strike new Zofran preemption evidence

    GSK fights bid to strike new Zofran preemption evidence

    Medical Dialogues Bureau20 Sept 2019 9:00 AM IST
    U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to...
    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Farhat Nasim19 Sept 2019 3:17 PM IST
    New Delhi: Taking cognizance of the grave concern of providing security and protection to Drug inspectors from threats, the Drugs Consultative...
    Lupin gets USFDA warning letter for Mandideep Unit-1 facility

    Lupin gets USFDA warning letter for Mandideep Unit-1 facility

    Medical Dialogues Bureau19 Sept 2019 1:07 PM IST
    Commenting on the same, Lupin said, "The Company does not believe that the warning letter will have an impact on the disruption of supplies or the...
    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Medical Dialogues Bureau19 Sept 2019 9:35 AM IST
    New Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    AVITA Medical wins USFDA nod for conducting trial of Recell System for treating skin defects

    AVITA Medical wins USFDA nod for conducting trial of Recell System for treating skin defects

    Garima19 Sept 2019 9:00 AM IST
    AVITA Medical will initiate a prospective, Multi-center, randomized controlled study to compare the clinical performance of conventional skin grafting...
    Apollo to separate out its pharmacy business, seeks shareholders nod

    Apollo to separate out its pharmacy business, seeks shareholders nod

    Farhat Nasim18 Sept 2019 5:37 PM IST
    New Delhi: Based on the directions of National Company Law Tribunal (NCLT), Apollo Hospitals Enterprise Ltd (AHEL) has proposed to hive off its...
    Roche wins USFDA breakthrough status for Gayzva for lupus nephritis

    Roche wins USFDA breakthrough status for Gayzva for lupus nephritis

    Medical Dialogues Bureau18 Sept 2019 9:45 AM IST
    Roche Gazyva is an engineered monoclonal antibody designed to attach to CD20, a protein found only on certain types of B-cells. It is thought to work...
    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

    Medical Dialogues Bureau18 Sept 2019 9:30 AM IST
    This new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
    After Michigan, NY state bans flavoured e-cigarettes over vaping concerns

    After Michigan, NY state bans flavoured e-cigarettes over vaping concerns

    Medical Dialogues Bureau18 Sept 2019 9:15 AM IST
    The ban comes into force with immediate effect. Michigan became the first state to declare a ban earlier this month, but that law has yet to be...
    Purdue Pharma secures permission to maintain business as bankruptcy unfolds

    Purdue Pharma secures permission to maintain business as bankruptcy unfolds

    Medical Dialogues Bureau18 Sept 2019 9:00 AM IST
    Purdue lawyers secured permission on Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying...
    PrevNext

    Popular Stories

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    Government to frame new rules on medical devices to draw investments

    Government to frame new rules on medical devices to draw investments

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Solara Active Pharma names Bharath R Sesha as new CEO

    Solara Active Pharma names Bharath R Sesha as new CEO

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok